Jiangsu Lanfeng Bio-chemical (002513.SZ)'s application for a targeted issuance of shares to specific targets has been accepted by the Shenzhen Stock Exchange.
Jiangsu Lanfeng Bio-chemical (002513.SZ) announced that on November 12, 2026, the company received the "Notice on Accepting the Application Documents for Issuing Shares to Specific Targets by Jiangsu Lanfeng Bio-chemical Co., Ltd." issued by the Shenzhen Stock Exchange (the "SZSE"). The SZSE reviewed the application documents for the issuance of shares to specific targets submitted by the company, determined that the application documents were complete, and decided to accept them.
Jiangsu Lanfeng Bio-chemical (002513.SZ) announced that on November 12, 2026, the company received the "Notice on Accepting the Application Documents for Jiangsu Lanfeng Bio-chemical Co., Ltd.'s Targeted Issuance of Shares to Specific Targets" issued by the Shenzhen Stock Exchange (the "SZSE"). The SZSE reviewed the application documents for the targeted issuance of shares to specific targets submitted by the company, determined that the application documents were complete, and decided to accept them.
Related Articles
Amid industry-wide jitters, it is still pushing ahead for the NYSE! "Nvidia-linked" neocloud Nscale updates its IPO prospectus: revenue surges 1,344%, with a massive single-quarter loss of US$1.69 billion.
AI capex peaks, global equity earnings shift gears! Goldman Sachs outlines three major themes for 2027.
Jensen Huang's Departure Doesn't Scare Wall Street! The Market Is Rushing to Grab the "Seat" Nvidia Is Vacating
Amid industry-wide jitters, it is still pushing ahead for the NYSE! "Nvidia-linked" neocloud Nscale updates its IPO prospectus: revenue surges 1,344%, with a massive single-quarter loss of US$1.69 billion.
AI capex peaks, global equity earnings shift gears! Goldman Sachs outlines three major themes for 2027.
Jensen Huang's Departure Doesn't Scare Wall Street! The Market Is Rushing to Grab the "Seat" Nvidia Is Vacating
